One marijuana industry insider says Monday's Truth Social video is a "trial balloon" testing support for marijuana legalization.In case you haven't heard, President Donald Trump just gave his "strongest signal yet that movement on cannabis policy may be imminent" and that the federal government may be ready to finally legalize marijuana use in the U.S. That's not just me saying that, either. On Monday, Adam Stettner, chief executive officer of FundCanna (a leading lender to the marijuana industry), explaine ...

Key Points President Trump posted a video yesterday touting the benefits of medical marijuana. The video also urged Medicare coverage of the drug. Green Thumb stock spiked on the news yesterday and today -- but remains cheap. 10 stocks we like better than Green Thumb Industries › Green Thumb Industries (OTC: GTBIF) stock, an over-the-counter traded, Chicago-based cannabis company, jumped more than 5% in early trading Tuesday before giving back most of its profits, and retreating to a 1% gain as of ...

Group 1 - The movement towards marijuana legalization in the U.S. has gained momentum, positively impacting shares of multistate operators like Curaleaf, which saw a gain of over 10% [1] - President Trump is considering a federal proposal to reclassify marijuana as a less harmful drug, indicating potential changes in federal policy [2] - Republican Congressman Greg Steube has introduced the "Marijuana 1-to-3 Act," aiming to reschedule marijuana from Schedule 1 to Schedule 3, which would effectively legalize it within 60 days of passing [3] Group 2 - Steube has been a long-time advocate for marijuana reform, emphasizing that loosening restrictions would significantly expand research opportunities [4] - Public support for marijuana legalization has increased dramatically, with a Gallup survey indicating 68% support in 2024, up from 36% in 2005, reflecting a shift in societal attitudes towards the drug [4]

Core Viewpoint - Tilray Brands is currently trading at its all-time low, having lost 94% of its value over the past five years, primarily due to the lack of marijuana legalization in the U.S. which investors had anticipated [1][4][10] Financial Performance - The company's total net revenue for the most recent quarter ended on February 28 was $185.8 million, reflecting a 1% decline [7] - Tilray reported an operating loss of $760 million, which included impairment charges of nearly $700 million [7] - The company burned through $5.8 million in cash from its day-to-day operations [7] Growth Strategy - Tilray has been pivoting towards alcohol to grow its top line, but this strategy has not generated sufficient growth to attract investors [5][6] - The company is exploring international cannabis markets and acquiring craft beer brands in the U.S. as potential growth avenues, but these efforts have not yielded significant results [6] Investment Considerations - The stock has been in a continuous decline, and buying it at a lower price has not proven to be a successful strategy [9] - Without a significant catalyst for growth or a clear path to profitability, the stock may not be a worthwhile investment at this time [10]